Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of insulin sensitization on IGF-1 responses to growth hormone in children born small for gestational age
2018-000584-85Phase 2Terminated
- Sponsor
- Rigshospitalet
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Growth disorder and growth disorder comparing Metformin + growth hormone with Placebo + growth hormone (2 arms). Primary endpoint: Circulating IGF-1 levels over 6 months. Started Mar 2018; status: terminated.
02
Drugs
metformin
03
Conditions
Growth disordergrowth disorder
Beyond the preview
Go deeper on 2018-000584-85.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000584-85.